Hypofractionated Chemoradiotherapy and Thymosin α1 in Unresectable or Recurrent Thymic Epithelial Tumor

NCT03663764 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

57

Enrollment

OTHER

Sponsor class

Conditions

Thymoma and Thymic Carcinoma

Interventions

DRUG: Thymosin a1
RADIATION: hypofractionated radiotherapy
DRUG: concurrent chemoradiotherapy

Sponsor

Sun Yat-sen University